Concepedia

Jean‐Michel Henlin

JH

Statistics

Publications

11

Citations

921

H-Index

10

Active since

1988

Affiliations

Servier (France)(Current)

Institut des Hautes Études Scientifiques

Institut de Pharmacologie Moléculaire et Cellulaire

Novartis (Switzerland)

Nantes Université

Jean‐Michel Henlin is an author at Servier (France) specializing in pharmacology, medicine, and oncology.

Publications per year

1988–2021

11

Publications

11

Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2

Olivier Nosjean, Myriam Ferro, Francis Cogé et al. · Journal of Biological Chemistry · 2000 · 596 citations · Full text

, , +14

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara, James Davidson, Audrey Clapéron et al. · Oncotarget · 2018 · 115 citations · Full text

, , +17

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara, James Davidson, Audrey Clapéron et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2018 · 48 citations

, , +17

NPY receptor subtypes involved in the contraction of the proximal colon of the rat

Michel Félétou, Marianne Rodriguez, Philippe Beauverger et al. · Regulatory Peptides · 1998 · 34 citations

, , +9

Combinatorial chemistry for the generation of molecular diversity and the discovery of bioactive leads

Jean‐Luc Fauchère, Jean A. Boutin, Jean‐Michel Henlin et al. · Chemometrics and Intelligent Laboratory Systems · 1998 · 33 citations

, , +16

1–5 of 11